| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/19/2013 | CA2876020A1 Polypeptides and antibodies for treating hbv infection and related diseases |
| 12/19/2013 | CA2875386A1 Antibody formulation |
| 12/19/2013 | CA2875096A1 Anti-pcsk9 antibodies, formulations, dosing, and methods of use |
| 12/18/2013 | EP2674485A1 PDX1-expressing dorsal and ventral foregut endoderm |
| 12/18/2013 | EP2674440A2 Multivalent immunoglobulin-based bioactive assemblies |
| 12/18/2013 | EP2674439A1 Anti-TrkA antibodies, derivatives and uses thereof |
| 12/18/2013 | EP2673635A2 Apoe immunotherapy |
| 12/18/2013 | EP2673373A2 Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use |
| 12/18/2013 | EP2673362A1 B-type plexin antagonists and uses thereof |
| 12/18/2013 | EP2673302A1 Pcsk9 antagonists |
| 12/18/2013 | EP2673301A2 Frmd4a antagonists and their uses |
| 12/18/2013 | EP2673300A1 Hla-restricted, peptide-specific antigen binding proteins |
| 12/18/2013 | EP2673299A1 Engineered immunoglobulin fc polypeptides |
| 12/18/2013 | EP2673298A1 Anti-gb3 antibodies useful in treating disorders associated with angiogenesis |
| 12/18/2013 | EP2673293A2 Surrogates of post-translationally modified proteins and uses thereof |
| 12/18/2013 | EP2672997A2 Treatment of osteoarthritis and pain |
| 12/18/2013 | EP2672996A2 Methods and systems for treating or preventing pregnancy-related hypertensive disorders |
| 12/18/2013 | EP2672994A1 Anti-alpha-v integrin antibody for the treatment of prostate cancer |
| 12/18/2013 | EP2672979A2 Anti cd4 antibodies to prevent in particular graft-versus-host-disease (gvhd) |
| 12/18/2013 | EP2209804B1 Monoclonal antibody for app |
| 12/18/2013 | EP2197918B1 Combination therapy with type i and type ii anti-cd20 antibodies |
| 12/18/2013 | EP2165715B1 Therapeutic agent for cancer, and method for treatment of cancer |
| 12/18/2013 | EP2057193B1 Ephb3-specific antibody and uses thereof |
| 12/18/2013 | EP1656952B1 Polyalkylene glycol conjugates of interferon beta-1A and uses thereof |
| 12/18/2013 | EP1648427B1 Low dose IgM antibody treatment of demyelinating disorders |
| 12/18/2013 | EP0647275B2 Cloning and expression of gonadotropin-releasing hormone receptor |
| 12/18/2013 | CN103460044A Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto |
| 12/18/2013 | CN103459595A Antibody against human prostaglandin E2 receptor EP4 |
| 12/18/2013 | CN103459427A Antigen-binding protein directed against epitope in the CH1 domain of human IgG antibodies |
| 12/18/2013 | CN103459426A Novel anti-human IL-23 receptor antibody |
| 12/18/2013 | CN103459425A Means and methods for treating DLBCL |
| 12/18/2013 | CN103459424A Anti - il1rap antibodies and their use for treating human |
| 12/18/2013 | CN103459423A Antibodies that bind tgf-alpha and epiregulin |
| 12/18/2013 | CN103459422A Multispecific antigen binding proteins targeting HGF |
| 12/18/2013 | CN103459421A Diagnostic antibody assay |
| 12/18/2013 | CN103459420A Compositions and methods for treating neoplasia |
| 12/18/2013 | CN103459414A Protein having antigen activity against liver flukes |
| 12/18/2013 | CN103458930A Human antibodies and antibody-drug conjugates against CD74 |
| 12/18/2013 | CN103458927A Treatment of fistulizing crohn's disease |
| 12/18/2013 | CN103454434A Elisa for vegf |
| 12/18/2013 | CN103454424A Quantitative enzyme-linked immuno sorbent assay (ELISA) detection method of neomycin phosphotransferase (NPT II) double-antibody sandwich in transgenic crops |
| 12/18/2013 | CN103454419A Immune colloidal gold test strip for detecting porcine epidemic diarrhea virus as well as preparation method and application thereof |
| 12/18/2013 | CN103451187A Recombinant neutrophil gelatinase associated lipocalin and preparation method of protein antibody |
| 12/18/2013 | CN103451156A Human HCRCN81 protein, as well as preparation and use of mouse anti-human monoclonal antibody |
| 12/18/2013 | CN103450360A Antibodies to cd40 |
| 12/18/2013 | CN103450359A Antagonist antibodies against GDF-8 and uses in treatment ofals and other GDF-8-associated disorders |
| 12/18/2013 | CN103450358A Swine GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase) protein antibody and preparation method and application thereof |
| 12/18/2013 | CN102816235B Preparation method of hybrid tumor of monoclonal antibody inhibiting common bacillus thuringiensis CryI, and application of monoclonal antibody thereof |
| 12/18/2013 | CN102558346B Monoclonal antibody anti-phiX174 phage splitting protein E, hybridoma cell strain producing antibody and epitope thereof |
| 12/18/2013 | CN102081094B Method for detecting patulin and special enzyme linked immunosorbent assay kit thereof |
| 12/18/2013 | CN101910200B Improved NOGO-A binding molecules and pharmaceutical use thereof |
| 12/18/2013 | CN101687909B Composition for preventing or treating lung disease |
| 12/18/2013 | CN101333244B Protein purification by ion exchange chromatography |
| 12/18/2013 | CN101124240B Specific binding agents to hepatocyte growth factor |
| 12/17/2013 | US8609822 Neutralizing antibodies and methods of use thereof |
| 12/17/2013 | US8609821 Antibodies against APRIL as biomarkers for early prognosis of lymphoma patients |
| 12/17/2013 | US8609820 Humanized antibodies that recognize alpha-synuclein |
| 12/17/2013 | US8609819 Extracellular serine protease |
| 12/17/2013 | US8609818 Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution |
| 12/17/2013 | US8609817 Anti-hepcidin-25 selective antibodies and uses thereof |
| 12/17/2013 | US8609816 Human monoclonal antibodies to O8E |
| 12/17/2013 | US8609610 Inhibitors of the trypsin-like site of the proteasome and methods of use thereof |
| 12/17/2013 | US8609605 Immunomodulatory methods for treatment of atherosclerosis via inhibition of CD4+ T cell response to APOB100 |
| 12/17/2013 | US8609435 Analyzing and typing monoclonal proteins by capillary electrophoresis and immunodisplacement |
| 12/17/2013 | US8609405 GABA neuron progenitor cell marker 65B13 |
| 12/17/2013 | US8609356 Method for diagnosing pulmonary artery hypertension |
| 12/17/2013 | US8609347 Biomarkers for prenatal diagnosis of congenital cytomegalovirus |
| 12/17/2013 | US8609111 Antibodies against clostridium difficile toxins and uses thereof |
| 12/17/2013 | US8609105 Auristatin drug linker conjugates |
| 12/17/2013 | US8609104 Treatment of B-cell cancers with anti-CD70 antibody-drug conjugates |
| 12/17/2013 | US8609101 Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies |
| 12/17/2013 | US8609100 Method for inhibiting dendritic cell immunoreceptor (DCIR)-mediated human immunodeficiency virus infection comprising administering anti-DCIR antibodies |
| 12/17/2013 | US8609092 Antibody drug conjugates (ADC) that bind to 161P2F10B proteins |
| 12/17/2013 | US8609091 Method for endocytic presentation of an immunosuppressive for the treatment of type 1 diabetes |
| 12/17/2013 | US8609090 Specific binding agents to hepatocyte growth factor |
| 12/17/2013 | DE212011100195U1 Antikörper, der das Tumorwachstum stoppt oder verzögert (Varianten) Antibody will stop tumor growth and delayed (variants) |
| 12/17/2013 | CA2674538C An insulinotropic complex using an immunoglobulin fragment |
| 12/17/2013 | CA2555413C An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof |
| 12/17/2013 | CA2459510C Food allergens, method of detecting food allergens and method of detecting food allergy-inducing foods |
| 12/17/2013 | CA2438698C Immunogen adherence inhibitor and method of making and using same |
| 12/17/2013 | CA2427310C Imaging, diagnosis and treatment of angiogenesis-related diseases comprising ecsm4 |
| 12/17/2013 | CA2410883C Methods for isolating and using fungal hemolysins |
| 12/17/2013 | CA2395423C P. gingivalis antigenic composition |
| 12/17/2013 | CA2370563C Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 12/17/2013 | CA2232813C Transgenic non-human animals capable of producing heterologous antibodies |
| 12/13/2013 | CA2816009A1 Anti-trka antibodies, derivatives and uses thereof |
| 12/12/2013 | WO2013185115A1 Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use |
| 12/12/2013 | WO2013185010A1 HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES |
| 12/12/2013 | WO2013184871A1 Caninized anti-ngf antibodies and methods thereof |
| 12/12/2013 | WO2013184761A1 Methods for making fully human bispecific antibodies using a common light chain |
| 12/12/2013 | WO2013184514A1 Site-specific labeling methods and molecules produced thereby |
| 12/12/2013 | WO2013184218A1 Human monoclonal antibodies against human chemokine receptor ccr6 |
| 12/12/2013 | WO2013183786A1 Antibody against transporter and use thereof |
| 12/12/2013 | WO2013183032A2 Anti-trka antibodies with enhanced inhibitory properties and derivatives thereof |
| 12/12/2013 | WO2013182602A1 Method for detecting and/or assaying annexin a3 from a mammal in blood or at least one derivative thereof |
| 12/12/2013 | US20130331553 Human toll homologues |
| 12/12/2013 | US20130331552 Means and methods for producing high affinity antibodies |
| 12/12/2013 | US20130331287 Autoimmune Antibodies |
| 12/12/2013 | US20130331282 Marker composition comprising s1p protein for prediction of risk in osteoporotic fracture and osteoporosis |
| 12/12/2013 | US20130330837 Monoclonal antibodies that target pathological assemblies of amyloid beta (abeta) |